Gero Revenue and Competitors

Gero is a longevity biotech company founded by a team of scientists and entrepreneurs with extensive experience in the area of life sciences. Our goal is to extend healthy lifespan dramatically and delay age-related health issues. We identify novel anti-aging targets, develop life-extending therapies and estimate personal risks of diseases and mortality with the help of AI and proprietary models. Why Gero? - Gero aims to develop interventions capable of dramatic life extension in humans - Gero has 5 years of fundamental research in aging - We discovered that Life extension in humans may be achieved in two ways: Fighting Frailty (small effect, late in life) Fighting True Aging (strong effect, early in life), and this is the way we chose unlike other anti-aging companies - We use causative models for drug discovery, and not correlative like OTHER AI-based longevity companies - We proved the efficacy of our technology in two species: round worms and in mice. - We are only one investment round away from getting our proof of concept in humans Please look at our project whitepaper here: https://www.frontiersin.org/articles/10.3389/fgene.2018.00483/full More publications here: https://gero.ai/publications